Loss of Homeostasis in the Direct Pathway in a Mouse Model of Asymptomatic Parkinson's Disease

被引:40
|
作者
Escande, Mariela V. [1 ,2 ]
Taravini, Irene R. E. [3 ,4 ,5 ]
Zold, Camila L. [1 ,2 ]
Belforte, Juan E. [1 ,2 ]
Gustavo Murer, M. [1 ,2 ]
机构
[1] Consejo Nacl Invest Cient & Tecn, IFIBIO Bernardo Houssay, Syst Neurosci Grp, RA-1121 Buenos Aires, DF, Argentina
[2] Univ Buenos Aires, Sch Med, Dept Physiol & Biophys, RA-1121 Buenos Aires, DF, Argentina
[3] Consejo Nacl Invest Cient & Tecn, ININFA, Expt Parkinsonism Grp, RA-1121 Buenos Aires, DF, Argentina
[4] Univ Buenos Aires, RA-1121 Buenos Aires, DF, Argentina
[5] Univ Entre Rios, Expt Neurobiol Lab, RA-2820 Concepcion Del Uruguay, Entre Rios, Argentina
关键词
6-OHDA; functional connectivity; in vivo electrophysiology; medium spiny neurons; striatum; STRIATAL PROJECTION NEURONS; MEDIUM SPINY NEURONS; EXTERNAL GLOBUS-PALLIDUS; BAC TRANSGENIC MICE; BASAL GANGLIA; IN-VIVO; STRIATOPALLIDAL NEURONS; L-DOPA; FEEDFORWARD INHIBITION; NIGROSTRIATAL DAMAGE;
D O I
10.1523/JNEUROSCI.0492-15.2016
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The characteristic slowness of movement in Parkinson's disease relates to an imbalance in the activity of striatal medium spiny neurons (MSNs) of the direct (dMSNs) and indirect (iMSNs) pathways. However, it is still unclear whether this imbalance emerges during the asymptomatic phase of the disease or if it correlates with symptom severity. Here, we have used in vivo juxtacellular recordings and transgenic mice showing MSN-type-specific expression of fluorescent proteins to examine striatal imbalance after lesioning dopaminergic neurons of the substantia nigra. Multivariate clustering analysis of behavioral data discriminated 2 groups of dopamine-lesioned mice: asymptomatic (42 +/- 7% dopaminergic neuron loss) and symptomatic (85 +/- 5% cell loss). Contrary to the view that both pathways have similar gain in control conditions, dMSNs respond more intensely than iMSNs to cortical inputs in control animals. Importantly, asymptomatic mice show significant functional disconnection of dMSNs from motor cortex without changes in iMSN connectivity. Moreover, not only the gain but also the timing of the pathways is altered in symptomatic parkinsonism, where iMSNs fire significantly more and earlier than dMSNs. Therefore, cortical drive to dMSNs decreases after partial nigrostriatal lesions producing no behavioral impairment, but additional alterations in the gain and timing of iMSNs characterize symptomatic rodent parkinsonism.
引用
收藏
页码:5686 / 5698
页数:13
相关论文
共 50 条
  • [41] Sex differences in motor behavior in the MPTP mouse model of Parkinson's disease
    Antzoulatos, Eleni
    Jakowec, Michael W.
    Petzinger, Giselle M.
    Wood, Ruth I.
    PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 2010, 95 (04) : 466 - 472
  • [42] Transgenic Mouse Models of Parkinson's Disease and Huntington's Disease
    Skaper, Stephen D.
    Giusti, Pietro
    CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS, 2010, 9 (04) : 455 - 470
  • [43] Histaminergic Activity in a Rodent Model of Parkinson's Disease
    Nowak, Przemyslaw
    Noras, Lukasz
    Jochem, Jerzy
    Szkilnik, Ryszard
    Brus, Halina
    Korossy, Eva
    Drab, Jacek
    Kostrzewa, Richard M.
    Brus, Ryszard
    NEUROTOXICITY RESEARCH, 2009, 15 (03) : 246 - 251
  • [44] Gadd45β ameliorates L-DOPA-induced dyskinesia in a Parkinson's disease mouse model
    Park, Hye-Yeon
    Ryu, Young-Kyoung
    Kim, Yong-Hoon
    Park, Tae-Shin
    Go, Jun
    Hwang, Jung Hwan
    Choi, Dong-Hee
    Rhee, Myungchull
    Lee, Chul-Ho
    Kim, Kyoung-Shim
    NEUROBIOLOGY OF DISEASE, 2016, 89 : 169 - 179
  • [45] Protective and therapeutic activity of honokiol in reversing motor deficits and neuronal degeneration in the mouse model of Parkinson's disease
    Chen, Hwei-Hsien
    Chang, Pei-Chi
    Chen, Chinpiao
    Chan, Ming-Huan
    PHARMACOLOGICAL REPORTS, 2018, 70 (04) : 668 - 676
  • [46] A New Synuclein-Transgenic Mouse Model for Early Parkinson's Reveals Molecular Features of Preclinical Disease
    Hendrickx, Diana M.
    Garcia, Pierre
    Ashrafi, Amer
    Sciortino, Alessia
    Schmit, Kristopher J.
    Kollmus, Heike
    Nicot, Nathalie
    Kaoma, Tony
    Vallar, Laurent
    Buttini, Manuel
    Glaab, Enrico
    MOLECULAR NEUROBIOLOGY, 2021, 58 (02) : 576 - 602
  • [47] EXERCISE IN AN ANIMAL MODEL OF PARKINSON'S DISEASE: MOTOR RECOVERY BUT NOT RESTORATION OF THE NIGROSTRIATAL PATHWAY
    Churchill, M. J.
    Pflibsen, L.
    Sconce, M. D.
    Moore, C.
    Kim, K.
    Meshul, C. K.
    NEUROSCIENCE, 2017, 359 : 224 - 247
  • [48] Neuronal loss in the caudal intralaminar thalamic nuclei in a primate model of Parkinson's disease
    Villalba, R. M.
    Wichmann, T.
    Smith, Y.
    BRAIN STRUCTURE & FUNCTION, 2014, 219 (01) : 381 - 394
  • [49] Altered glutamate release in the dorsal striatum of the MitoPark mouse model of Parkinson's disease
    Farrand, Ariana Q.
    Gregory, Rebecca A.
    Backman, Cristina M.
    Helke, Kristi L.
    Boger, Heather A.
    BRAIN RESEARCH, 2016, 1651 : 88 - 94
  • [50] Exendin-4 and linagliptin attenuate neuroinflammation in a mouse model of Parkinson's disease
    Yu, Hai-Yang
    Sun, Tong
    Wang, Zhen
    Li, Hong
    Xu, Duo
    An, Jing
    Wen, Lu-Lu
    Li, Jia-Yi
    Li, Wen
    Feng, Juan
    NEURAL REGENERATION RESEARCH, 2023, 18 (08) : 1818 - 1826